Research Article


DOI :10.26650/experimed.1401479   IUP :10.26650/experimed.1401479    Full Text (PDF)

Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response

Murat Basar

Objective: Gonadotropin-releasing hormone agonist (GnRHa) trigger induces both Luteinizing hormone (LH) and follicle stimulating hormone (FSH) surges, impacting oocyte maturation, and mitochondrial dysfunction, is responsible for chromosomal anomalies during meiotic divisions. This study aimed to investigate the effect of GnRHa instead of human chorionic gonadotropin (hCG) triggers on unfolded protein responses against embryonic stress in oocytes and embryos.

Materials and Methods: Female mice were divided into control, hCG-triggered, and GnRHa-triggered groups. Superovulation was performed. Oocytes were retrieved 13h after hCG or GnRHa injection, and two pronuclei (2PN) oocytes were retrieved 24h after the appearance of a vaginal plug. ATF5, GRP78, and HSP60 protein levels were analyzed by Western blot. One-way ANOVA and Students' t-test were used for statistical analysis.

Results: When comparing the GnRHa group to the hCG group, their respective oocyte maturation rates (79.8% vs. 75.9%), oocyte areas (10198 μm2 and 9474 μm2), 2PN rates (78% vs. 72%), and blastocyst formation rates (82% vs. 77%) were significantly higher (p < 0.05). The HSP60 protein level was significantly lower in the GnRHa group compared to the hCG group (22% vs. 55%, p < 0.05). Additionally, the ATF5 protein level was significantly lower in the hCG group compared to the GnRHa group (p < 0.0001).

Conclusion: GnRHa trigger improves oocyte nuclear and cytoplasmic maturation, as well as blastocyst formation rates. The underlying mechanism for this effect is the downregulation of HSP60 and upregulation of ATF5 levels.


PDF View

References

  • Hu KL, Wang S, Ye X, Zhang D, Hunt S. GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials. Reprod Biol Endocrinol 2021; 19(1): 78. google scholar
  • Gao F, Wang Y, Fu M, Zhang Q, Ren Y, Shen H, Han H. Effect of a “Dual Trigger” using a GnRH agonist and hCG on the cumulative live-birth rate for normal responders in GnRH-antagonist cycles. Front Med (Lausanne) 2021; 8: 683210. google scholar
  • Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006; 12(2): 159-68. google scholar
  • Basar M, Bozkurt I, Guzeloglu-Kayisli O, Sozen B, Tekmen I, Schatz F, et al. Unfolded protein response prevents blastocyst formation during preimplantation embryo development in vitro. Fertil Steril 2014; 102(6): 1777-84. google scholar
  • Khatun H, Ihara Y, Takakura K, Egashira J, Wada Y, Konno T, et al. Role of endoplasmic reticulum stress on developmental competency and cryo-tolerance in bovine embryos. Theriogenology 2020; 142: 131-7. google scholar
  • Michalak M, Gye MC. Endoplasmic reticulum stress in periimplantation embryos. Clin Exp Reprod Med 2015; 42(1) :1-7. google scholar
  • Kumar R, Chaudhary AK, Woytash J, Inigo JR, Gokhale AA, Bshara W, et al. A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. J Clin Invest 2022; 132(13): e149906. google scholar
  • Seli E, Lalioti MD, Flaherty SM, Sakkas D, Terzi N, Steitz JA. An embryonic poly(A)-binding protein (ePAB) is expressed in mouse oocytes and early preimplantation embryos. Proc Natl Acad Sci U S A 2005; 102(2): 367-72. google scholar
  • Baart EB, Macklon NS, Fauser BJ. Ovarian stimulation and embryo quality. Reprod Biomed Online 2009; 18 Suppl 2: 45-50. google scholar
  • Andersen CY, Humaidan P, Ejdrup HB, Bungum L, Grondahl ML, Westergaard LG. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction. Hum Reprod 2006; 21(8): 2126-30. google scholar
  • Humaidan P, Alsbjerg B. GnRHa trigger for final oocyte maturation: Is HCG trigger history? Reprod Biomed Online 2014; 29(3): 274-80. google scholar
  • Humaidan P, Kol S, Papanikolaou EG, Copenhagen Gn RHATWG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 2011; 17(4): 510-24. google scholar
  • Sukur YE, Ozmen B, Ozdemir ED, Seval MM, Kalafat E, Sonmezer M, et al. Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome. Reprod Biomed Online 2017; 34(1): 5-10. google scholar
  • Yang BC, Uemura T, Minaguchi H. Effects of a gonadotropin releasing hormone agonist on oocyte maturation, fertilization, and embryonal development of mice. J Assist Reprod Genet 1995; 12(10): 728-32. google scholar
  • Moehle EA, Shen K, Dillin A. Mitochondrial proteostasis in the context of cellular and organismal health and aging. J Biol Chem 2019; 294(14): 5396-407. google scholar
  • Dumollard R, Duchen M, Carroll J. The role of mitochondrial function in the oocyte and embryo. Curr Top Dev Biol 2007; 77: 21-49. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Basar, M. (2024). Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed, 14(1), 21-25. https://doi.org/10.26650/experimed.1401479


AMA

Basar M. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed. 2024;14(1):21-25. https://doi.org/10.26650/experimed.1401479


ABNT

Basar, M. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed, [Publisher Location], v. 14, n. 1, p. 21-25, 2024.


Chicago: Author-Date Style

Basar, Murat,. 2024. “Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response.” Experimed 14, no. 1: 21-25. https://doi.org/10.26650/experimed.1401479


Chicago: Humanities Style

Basar, Murat,. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response.” Experimed 14, no. 1 (May. 2024): 21-25. https://doi.org/10.26650/experimed.1401479


Harvard: Australian Style

Basar, M 2024, 'Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response', Experimed, vol. 14, no. 1, pp. 21-25, viewed 3 May. 2024, https://doi.org/10.26650/experimed.1401479


Harvard: Author-Date Style

Basar, M. (2024) ‘Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response’, Experimed, 14(1), pp. 21-25. https://doi.org/10.26650/experimed.1401479 (3 May. 2024).


MLA

Basar, Murat,. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response.” Experimed, vol. 14, no. 1, 2024, pp. 21-25. [Database Container], https://doi.org/10.26650/experimed.1401479


Vancouver

Basar M. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed [Internet]. 3 May. 2024 [cited 3 May. 2024];14(1):21-25. Available from: https://doi.org/10.26650/experimed.1401479 doi: 10.26650/experimed.1401479


ISNAD

Basar, Murat. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response”. Experimed 14/1 (May. 2024): 21-25. https://doi.org/10.26650/experimed.1401479



TIMELINE


Submitted07.12.2023
Accepted20.02.2024
Published Online25.03.2024

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.